TC BioPharm (Holdings) plc Annual Net Income (Loss) Attributable to Parent in GBP from 2022 to 2023

Taxonomy & unit
us-gaap: GBP
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
TC BioPharm (Holdings) plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2022 to 2023.
  • TC BioPharm (Holdings) plc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -£3.32M, a 423% decline year-over-year.
  • TC BioPharm (Holdings) plc annual Net Income (Loss) Attributable to Parent for 2023 was -£5.91M, a 350% decline from 2022.
Net Income (Loss) Attributable to Parent, Annual (GBP)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -5.91M -4.59M -350% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -1.31M Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.